4
DRY RUN - Act against AMR: Managing UTI with the Latest Susceptibility data
Act against AMR: Managing UTI with the Latest Susceptibility data
This webinar talks about common epidemiology of UTI, its prevalence amongst women and how a proper guideline-treatment plan helps combat antimicrobial resistance in patients.
Nucala is now approved in 4 indications in Saudi Arabia and the objective of the meeting is to raise Saudi HCPs awareness about the management of Eosinophilic Driven Diseases
Speakers

Jeff J. Jubilado, MD
MHA, FPUA, FPCS, FICS
Present roles: Chief of Clinics & Department Chair (Surgery) -- Assumption Specialty Hospital and Medical Center ** Department Chair (Surgery) -- Pasig Doctors Medical Center. ** Department Chair (Urology) -- Marikina Valley Medical Center. ** Section Head (Urology) -- Marikina Doctors Hospital and Medical Center. ** Member American Urological Association European Association of Urology Urological Association of Asia ** Medical Affairs Manager (Urology) -- GSK Philippines

Allan Dexter M. Alejo, MD
DPDS
Medical Affairs Manager -- Anti-infectives and Dermatology, GSK Philippines.** Doctor of Medicine -- UST Faculty of Medicine and Surgery. ** Residency in Dermatology -- Skin and Cancer Foundation, Inc. ** Diplomate -- Philippine Dermatological Society.
PM-PH-ACA-WCNT-230002